Abstract CT059: Phase 1b trial Mipasetamab Uzoptirine (ADCT-601-102) dose escalation in patients with advanced bone and soft tissue sarcomas
Year: 2024
Type: conference-abstract
Source: Cancer Research
Authors: Brian Andrew Van Tine, Christopher T. Chen, Victor Moreno, Elizabeth J. Davis, Maria J. de Miguel, Antoine Italiano, Esma Saada-Bouzid, Mohammed Milhem, Claudia Valverde, Sant P. Chawla, Abdul Rafeh Naqash, Louise Carter, Robin Jones, Ilaria Conti, Joe Boni, Karin Havenith, Yvan LeBruchec, Serafino Pantano, Jean-Yves Blay
Institutions: Washington University in St. Louis, Stanford University, Hospital Universitario Fundación Jiménez Díaz, Vanderbilt University Medical Center, Hospital Universitario HM Sanchinarro, Institut Bergonié, Université Côte d'Azur, Centre Antoine Lacassagne, University of Iowa, Vall d'Hebron Hospital Universitari, Sarcoma Oncology Center, OU Health Stephenson Cancer Center, University of Oklahoma, The Christie NHS Foundation Trust, Royal Marsden NHS Foundation Trust, Adc Therapeutics (Switzerland), Centre Léon Bérard
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4393988945